5-Amino-1MQ 100 mg research pen
The NNMT inhibitor at one hundred milligrams, a small molecule, not a peptide, stocked for the metabolism-research corner and labelled for what it is.
- ISO-certified laboratory
- COA per batch, ≥99% HPLC
- Discreet dispatch within 24 h
- Research use only
A small molecule on a peptide shelf
5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), an enzyme that intersects NAD+ metabolism, which is how a non-peptide small molecule earned its place in this catalogue and its honest classification on every page that mentions it, starting with the definition page.
The 100 mg fill reflects small-molecule research economics: cheaper synthesis, larger working quantities than peptide signalling work uses. Animal-model evidence, human data absent, the compound page holds that line.
| Compound | 5-Amino-1MQ |
| Content | 100 mg, pre-filled |
| Class | Small molecule, not a peptide |
| Target | NNMT |
| Purity | ≥ 99% (HPLC) |
| Evidence base | Animal models |
| Category | Research use only |
Its NAD+ connection is mechanistic, not chemical, the pages keep the two molecules apart.
Before the 5-Amino-1MQ 100 mg research pen reaches the bench
Small molecules forgive more than peptides; follow the pen rules anyway.
Small molecule, same discipline
A small molecule forgives more than a peptide, which is no reason to relax.
As a small molecule rather than a peptide, 5-Amino-1MQ tolerates handling that would degrade a fragile chain, which tempts casual handling of the hundred-milligram pen. Ignore the temptation. Keep the cartridge refrigerated between sessions, capped and out of direct light, exactly as the storage page requires, treating the extra robustness as a safety margin, not a licence. A compound that forgives a warm afternoon keeps a cleaner record when it never has to, and reproducibility is built from those small refusals to cut corners.
Write the first-use date on the pen and let the fill last as long as its condition, not its volume, allows. Small-molecule work draws larger quantities than peptide work, so the cartridge is sized for a longer campaign, which makes steady storage more worthwhile, since more experiments ride on one tube staying good. Refrigerate it on arrival, log the date, and let that record set the cutoff. The chemistry forgives; a record built on guesswork about exposure time does not.
The metabolism corner, placed precisely
Where the NNMT inhibitor sits among its metabolism-corner neighbours.
Within the catalogue’s metabolism corner, 5-Amino-1MQ sits beside NAD+, and the relationship is easy to overstate. The link is mechanistic, not chemical: this compound inhibits nicotinamide N-methyltransferase, an enzyme that intersects NAD+ metabolism, which is how the two share a research neighbourhood without sharing a molecule. It is also the shelf’s other declared non-peptide, standing next to the coenzyme as a second entry that earns its place by relevance rather than by fitting the catalogue’s name. The facts panel states as much plainly.
That placement carries a caution the neighbours make plain. Where the epitalon pen nearby arrives wrapped in longevity claims, this compound’s evidence is animal-model work with human data absent, a state of affairs plain from the 5-Amino-1MQ search on PubMed, and the page holds that line rather than borrowing NAD+’s literature. The hundred-milligram fill reflects small-molecule economics, cheap to make, used in larger amounts, not a vote of confidence in the data. A researcher planning to buy 5-amino-1mq is buying a well-placed question, sized honestly to its animal evidence.
The metabolism corner
The coenzyme it intersects, and the shelf’s other famous non-success-story.
The science behind 5-Amino-1MQ
Classification, mechanism, context.
Questions about the 5-Amino-1MQ 100 mg research pen
For the shelf’s other non-peptide.